This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
A Astrup , GK Grunwald , EL Melanson , WH Saris & JO Hill (2000) The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Dis 24, 1545–1552.
J Cooling & JE Blundell (2000) Lean male high- and low-fat phenotypes – different routes for achieving energy balance. Int J Obesity 24, 1561–1566.
JK Cruickshank , AH Heald & S Anderson (2001) Epidemiology of the insulin-like growth factor system in three ethnic groups. Am J Epidemiol 154, 504–513.
JM De Castro (1994) Methodology, correlation analysis, and interpretation of diet diary records of the food and fluid intake of free-living humans. Appetite 23, 179–192.
CC DiClemente & JO Prochaska (1998) Toward a comprehensive, transtheoretical model of change: stages of change and addictive behaviors. In Treating Addictive Behaviors. 2nd ed. 3 – 24 [ WR Miller and N Heather , editors ] New York: Plenum Press.
M Dittmar (2003) Reliability and variability of bioimpedance measures in normal adults: effects of age, gender, and body mass. Am J Phys Anthropol 122, 361–370.
JR Downs , M Clearfield , S Weis , E Whitney , DR Shapiro , PA Beere , A Langendorfer , EA Stein , W Kruyer & AM Jr Gotto (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279, 1615–1622.
A Festa , R D'Agostino Jr, G Howard , L Mykkanen , RP Tracy & SM Haffner (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102, 42–47.
A Festa , R D'Agostino Jr, K Williams , AJ Karter , EJ Mayer-Davis , RP Tracy & SM Haffner (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407–1415.
F Fidanza , V Puddu , AB Imbimbo , A Menotti & A Keys (1970) Coronary heart disease in seven countries. VII. Five-year experience in rural Italy. Circulation 41, Suppl 4. I63–I75.
GW Greene & SR Rossi (1998) Stages of change for reducing dietary fat intake over 18 months. J Am Diet Assoc 98, 529–534.
AH Heald , SG Anderson , F Ivison , I Laing , JM Gibson & JK Cruickshank (2003 a) C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 170, 79–86.
AH Heald , JK Cruickshank & LK Riste (2001) Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44, 333–339.
ML Hellenius , KE Brismar , BH Berglund & U de Faire (1995) Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med 238, 121–130.
L Hooper , CD Summerbell , JP Higgins , RL Thompson , NE Capps , GD Smith , RA Riemersma & S Ebrahim (2001) Dietary fat intake and prevention of cardiovascular disease. BMJ 322, 757–763.
JAMJL Janssen , RP Stolk , HAP Pols , DE Grobbee & SWJ Lamberts (1998) Serum total IGF-I, free IGF-I and IGFBP-1 levels in an elderly population. Arterioscler Thromb Vasc Biol 18, 277–282.
R Kaaks , C Bellati , E Venturelli , S Rinaldi , G Secreto , C Biessy , V Pala , S Sieri & F Berrino (2003) Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr 57, 1079–1088.
DP Keenan , C Achterberg , PM Kris-Etherton , R AbuSabha , A Von Eye (1996) Use of qualitative and quantitative methods to define behavioral fat-reduction strategies and their relationship to dietary fat reduction in the patterns of dietary change study. J Am Diet Assoc 96, 1245–1250 1253.
A Keys (1975) Coronary heart disease – the global picture. Atherosclerosis 22, 149–192.
CL Lawton , HJ Delargy , FC Smith , V Hamilton & JE Blundell (1998) A medium-term intervention study on the impact of high- and low-fat snacks varying in sweetness and fat content: large shifts in daily fat intake but good compensation for daily energy intake. Br J Nutr 80, 49–61.
HM Lloyd , CM Paisley & DJ Mela (1995) Barriers to the adoption of reduced-fat diets in a UK population. J Am Diet Assoc 95, 316–322.
DR Matthews , JB Hosker , AS Rudenski , BA Naylor , DF Treacher & RC Turner (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
CI Pao , PK Farmer , S Begovic , S Goldstein , GJ Wu & LS Phillips (1992) Expression of hepatic insulin-like growth factor-I and insulin-like growth factor binding protein-1 genes is transcriptionally regulated in streptozotocin-diabetic rats. Mol Endocrinol 6, 969–977.
LS Phillips , S Goldstein & CI Pao (1991) Nutrition and somatomedin. XXVI. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes. Diabetes 40, 1525–1530.
S Pirozzo , C Summerbell , C Cameron & P Glasziou (2003) Should we recommend low fat diets for obesity? Obes Rev 4, 83–90.
LS Rallidis , G Paschos , GK Liakos , AH Velissaridou , G Anastasiadis & A Zampelas (2003) Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167, 237–242.
PM Ridker , JE Buring , NR Cook & Rifai N Nader (2003) C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107, 391–397.
L Roe , C Strong , C Whiteside , A Neil & D Mant (1994) Dietary intervention in primary care: validity of the DINE method for diet assessment. Fam Pract 11, 375–381.
MS Sandhu , AH Heald , JM Gibson , JK Cruickshank , DB Dunger & NJ Wareham (2002) Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359, 1740–1745.
PS Sever , B Dahlof & NR Poulter (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361, 1149–1158.
J Shepherd , SM Cobbe , I Ford , CG Isles , AR Lorimer , PW MacFarlane , JH McKillop & CJ Packard (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333, 1301–1307.
J Stephenson & J Imrie (1998) Why do we need randomised controlled trials to assess behavioural interventions? BMJ 316, 611–613.
N Vaessen , P Heutink , JA Janssen , JC Witteman , L Testers , A Hofman , SW Lamberts , BA Oostra , HA Pols & CM van Duijn (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50, 637–642.
M Westwood , JM Gibson , AJ Davies , RJ Young & A White (1994) The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 79, 1735–1741.